These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7359119)

  • 21. Electroconvulsive therapy in the treatment of combined depression and Parkinson's disease.
    Burke WJ; Peterson J; Rubin EH
    Psychosomatics; 1988; 29(3):341-6. PubMed ID: 3406352
    [No Abstract]   [Full Text] [Related]  

  • 22. Treating the progressive stages of Parkinson's disease.
    Varon J; Jacobs MB
    Postgrad Med; 1991 Jul; 90(1):63-6, 69-71. PubMed ID: 1905807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
    Simioni AC; Dagher A; Fellows LK
    Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The on-off effect in Parkinson's disease treated with levodopa with remarks concerning the effect of sleep.
    Clark EC; Feinstein B
    Adv Exp Med Biol; 1977; 90():175-82. PubMed ID: 930742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study.
    Ouma S; Fukae J; Fujioka S; Yamamoto S; Hatano T; Yoritaka A; Okuma Y; Kashihara KI; Hattori N; Tsuboi Y
    Intern Med; 2017; 56(15):1961-1966. PubMed ID: 28768964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatial disorientation in Parkinson's disease: no effect of levodopa substitution therapy.
    Hovestadt A; De Jong GJ; Meerwaldt JD
    Neurology; 1988 Nov; 38(11):1802-3. PubMed ID: 3185919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease, depression, and electroconvulsive therapy: a clinical and neurobiologic synthesis.
    Yudofsky SC
    Compr Psychiatry; 1979; 20(6):579-81. PubMed ID: 41677
    [No Abstract]   [Full Text] [Related]  

  • 28. Rational management of the 'on-off' syndrome in Parkinson's disease.
    Coleman RJ
    Q J Med; 1990 Feb; 74(274):121-31. PubMed ID: 2189148
    [No Abstract]   [Full Text] [Related]  

  • 29. L-tryptophan supplementation in Parkinson's disease.
    Sandyk R; Fisher H
    Int J Neurosci; 1989 Apr; 45(3-4):215-9. PubMed ID: 2744962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of deep brain stimulation and levodopa on postural sway in subjects with Parkinson's disease.
    Burn DJ
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):240. PubMed ID: 12185151
    [No Abstract]   [Full Text] [Related]  

  • 31. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients].
    Hironishi M; Miwa H; Kondo T
    No To Shinkei; 2002 Feb; 54(2):127-32. PubMed ID: 11889758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
    Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
    J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smooth pursuit during dose-related on-off fluctuations in Parkinson's disease.
    Sharpe JA; Fletcher WA; Lang AE; Zackon DH
    Neurology; 1987 Aug; 37(8):1389-92. PubMed ID: 3614666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinson's disease, depression, and the on-off phenomenon.
    Friedenberg DL; Cummings JL
    Psychosomatics; 1989; 30(1):94-9. PubMed ID: 2913602
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of previous stereotactic thalamotomy on l-dopa therapy in Parkinson's disease.
    Selby G
    Proc Aust Assoc Neurol; 1976; 13():55-60. PubMed ID: 800866
    [No Abstract]   [Full Text] [Related]  

  • 36. Abdominal pain: a symptom of levodopa end of dose wearing off in Parkinson's disease.
    Rana AQ; Depradine J
    West Indian Med J; 2011 Mar; 60(2):223-4. PubMed ID: 21942133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Madopar HBS. International workshop on the 'on-off-phenomenon in Parkinson's disease. New possibilities for its management. Agno, November 14-16, 1985.
    Eur Neurol; 1987; 27 Suppl 1():1-142. PubMed ID: 3428304
    [No Abstract]   [Full Text] [Related]  

  • 38. A 61-year-old man with Parkinson's disease.
    Olanow CW
    JAMA; 1996 Mar; 275(9):716-22. PubMed ID: 8594271
    [No Abstract]   [Full Text] [Related]  

  • 39. [Initial management and adaptation of Parkinson's disease treatment].
    Gérard JM
    Rev Med Brux; 2008 Sep; 29(4):229-31. PubMed ID: 18949969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies.
    Mouradian MM; Juncos JL; Fabbrini G; Chase TN
    Ann Neurol; 1987 Oct; 22(4):475-9. PubMed ID: 3435068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.